AZZ Says Conducting Board-led Review Of Portfolio And Capital Allocation - Quick Facts

AZZ Inc. (AZZ) said Thursday that it is conducting a comprehensive Board-led review of its portfolio and capital allocation, and has engaged independent financial, legal and tax advisors in support of this review.

The company noted that these actions will allow it to accelerate the strategy to become a focused metal coatings company and rapidly enhance shareholder value.

Tom Ferguson, President and Chief Executive Officer of AZZ, said that prior to the onset of COVID-19, the company divested NLI and reduced its exposure to the nuclear sector. The company also divested the AZZ SMS business in Florida as well as other non-core assets despite delays arising from COVID-19.

"Our review of the Infrastructure Solutions businesses and associated assets and the exploration of other capital allocation opportunities to maximize shareholder value - with the assistance of independent advisors - is the next important step in this process," Ferguson added.

In addition, AZZ has repurchased over 500,000 shares over the past five months and authorized a new stock repurchase program of $100 million that it intends to complete by the end of fiscal year 2022.

As part of the review, AZZ has engaged an independent search firm to further its Board refreshment process.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The five-day holiday shopping period from Thanksgiving Day through Cyber Monday saw about 180 million Americans making in-store and online purchases, according to the National Retail Federation's Annual Thanksgiving Weekend Consumer Survey, conducted by Prosper Insights & Analytics. The shoppers spent an average of $301.27 on holiday-related purchases such as gifts, décor, apparel and toys. Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529). Based upon structural mapping of those mutations and activity against previous and current CDC variants of concern,... CVS Health said it has installed time delay safe technology in all 392 Illinois CVS Pharmacy locations, including those in Target stores, to help reduce organized retail crime. The installation of new safes for controlled substances are anticipated to help prevent pharmacy robberies. There is also potential for associated diversion of controlled substance medications, including opioid medications.
Follow RTT